Adriana M Kahn (Adriana Matutino, Adriana Kahn)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Venues

Future oncology (London, England)

Therapeutic advances in medical oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Breast cancer research and treatment

Tom Baker Cancer Centre

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tom Baker Cancer Centre Jul 26 2016 - Jun 26 2018

Canada

Breast Cancer Clinical Research Fellow :: Medical Oncology

Publications

Julia Foldi, Kim R M Blenman, Michał Marczyk, Vignesh Gunasekharan, Alicja Polanska, Renelle Gee, Mya Davis, Adriana M Kahn, Andrea Silber, Lajos Pusztai
Peripheral blood immune parameters, response, and adverse events after neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast cancer. Breast cancer research and treatment (2024)
Rachel Jaber Chehayeb, Adriana M Kahn, Lajos Pusztai
Treatment efficacy score: a better surrogate for arm-level survival differences in neoadjuvant breast cancer trials? Future oncology (London, England) (2023)
Adriana M Kahn, Curtis J Perry, Katrina Etts, Harriet Kluger, Mario Sznol
Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors. The oncologist (2023)
Julia Foldi, Adriana M Kahn, Andrea L M Silber, Tao Qing, Emily Reisenbichler, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Anees Chagpar, Tristen Park, Adam Blanchard, Kim R M Blenman, David L Rimm, Lajos Pusztai
Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Adriana M Kahn, Carla Amaro, Sunil Verma
CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease. Therapeutic advances in medical oncology 10 (2018)

Adriana M Kahn.css-eqlu8i{font-size:small;padding-left:4px;} (Adriana Matutino, Adriana Kahn)

Publication Activity (10 Years)

Top Topics

Top Venues

Adriana M Kahn (Adriana Matutino, Adriana Kahn)